VITALE, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 9.021
AS - Asia 3.771
EU - Europa 3.616
SA - Sud America 553
AF - Africa 85
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 17.054
Nazione #
US - Stati Uniti d'America 8.905
GB - Regno Unito 1.435
SG - Singapore 1.184
CN - Cina 1.097
IT - Italia 508
VN - Vietnam 444
HK - Hong Kong 429
BR - Brasile 426
SE - Svezia 355
DE - Germania 306
FR - Francia 177
UA - Ucraina 165
FI - Finlandia 164
RU - Federazione Russa 163
KR - Corea 110
TR - Turchia 97
IN - India 92
IE - Irlanda 88
BG - Bulgaria 68
CA - Canada 58
BD - Bangladesh 43
AR - Argentina 39
ID - Indonesia 36
MX - Messico 32
IQ - Iraq 30
NL - Olanda 30
ZA - Sudafrica 29
AE - Emirati Arabi Uniti 28
JP - Giappone 27
PK - Pakistan 23
ES - Italia 22
CO - Colombia 21
MY - Malesia 21
PL - Polonia 19
BE - Belgio 18
VE - Venezuela 18
CL - Cile 17
EC - Ecuador 17
BY - Bielorussia 15
UZ - Uzbekistan 13
PH - Filippine 12
SA - Arabia Saudita 11
LT - Lituania 10
CZ - Repubblica Ceca 9
MA - Marocco 9
PT - Portogallo 9
PY - Paraguay 9
EG - Egitto 8
AT - Austria 7
AZ - Azerbaigian 7
NP - Nepal 7
RO - Romania 7
TH - Thailandia 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
KE - Kenya 6
KZ - Kazakistan 6
AU - Australia 5
DZ - Algeria 5
GE - Georgia 5
HU - Ungheria 5
IL - Israele 5
JO - Giordania 5
TT - Trinidad e Tobago 5
AL - Albania 4
CH - Svizzera 4
CR - Costa Rica 4
ET - Etiopia 4
LB - Libano 4
LU - Lussemburgo 4
NO - Norvegia 4
PS - Palestinian Territory 4
SI - Slovenia 4
BO - Bolivia 3
CY - Cipro 3
GR - Grecia 3
HN - Honduras 3
LY - Libia 3
MM - Myanmar 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AM - Armenia 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
EE - Estonia 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
NI - Nicaragua 2
UY - Uruguay 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
Totale 17.041
Città #
Southend 1.111
Ashburn 882
Santa Clara 811
Fairfield 804
Singapore 754
Woodbridge 562
Chandler 464
Hong Kong 416
Houston 406
Hefei 366
Seattle 357
Jacksonville 347
Wilmington 292
Dearborn 291
Cambridge 290
Ann Arbor 288
Chicago 244
Beijing 225
San Jose 219
Nyköping 201
Los Angeles 182
London 159
Ho Chi Minh City 125
The Dalles 117
Council Bluffs 116
Modena 116
Helsinki 101
Hanoi 96
New York 96
Seoul 92
Salt Lake City 90
Dublin 85
Princeton 75
San Diego 67
Sofia 64
Dallas 58
Eugene 57
Izmir 53
Lauterbourg 51
Buffalo 49
Moscow 48
Elk Grove Village 42
Des Moines 41
Milan 41
São Paulo 40
Frankfurt am Main 36
Bremen 32
Munich 30
Tampa 30
Redwood City 28
Toronto 28
Fremont 27
Phoenix 26
Tokyo 25
Boardman 24
Falls Church 24
Lancaster 24
Da Nang 23
Orem 23
Haiphong 22
Columbus 21
Sterling 21
Chennai 20
Shanghai 20
Brooklyn 19
Miami 18
Norwalk 17
Brussels 16
Warsaw 16
Jakarta 15
Johannesburg 15
Ferrara 14
Pittsburgh 14
Bologna 13
Detroit 13
Mexico City 13
Rome 13
Seongnam 13
Atlanta 12
Parma 12
Tashkent 12
Amsterdam 11
Biên Hòa 11
Kansas City 11
Paris 11
Poplar 11
Rio de Janeiro 11
Wuhan 11
Baghdad 10
Kent 10
Las Vegas 10
Nanjing 10
Naples 10
Denver 9
Dong Ket 9
Dulles 9
Montreal 9
Mumbai 9
New Delhi 9
Brasília 8
Totale 12.309
Nome #
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 489
ANXIOLYTIC LIKE EFFECT OF NEUROPEPTIDE S IN THE RAT DEFENSIVE BURYING. 451
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 409
Acute noise stress analgesia in relation to 5-HT2 and mu-opioid receptor changes in the frontal cortex of young mice 407
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 395
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 393
Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. 367
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 358
Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet 343
CCAP regulates feeding behavior via the NPF pathway in Drosophila adults 341
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 338
Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats 337
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 336
Collagen VI regulates peripheral nerve regeneration by modulating macrophage recruitment and polarization 335
[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies. 329
Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation. 326
Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 323
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 309
Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system 302
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 301
Gamma-hydroxybutyrate increases gastric emptying in rats 293
Structure Model and Toxicity of the Product of Biodissolution of Chrysotile Asbestos in the Lungs 291
Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain 279
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 275
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 273
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505 271
BV-2 Microglial Cells Respond to Rotenone Toxic Insult by Modifying Pregnenolone, 5alpha-Dihydroprogesterone and Pregnanolone Level 267
Headaches associated with chronic use of analgesics: A therapeutic approach 261
Effect of rofecoxib on nociception and the serotonin system in the rat brain 260
Disposition of naproxen after oral administration during and between migraine attacks. 259
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 258
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 251
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 250
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 249
In vitro toxicity of fibrous glaucophane 248
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 246
Acute cytotoxicity of mineral fibres observed by time-lapse video microscopy 244
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 243
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 241
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 237
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 235
Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain 231
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 226
Glutamate-mediated astrocyte-to-neuron signaling in the rat dorsal horn 225
Human microglia synthesize neurosteroids to cope with rotenone-induced oxidative stress 224
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 220
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 220
Disclosing the Antioxidant and Neuroprotective Activity of an Anthocyanin-Rich Extract from Sweet Cherry (Prunus avium L.) Using In Vitro and In Vivo Models 215
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 214
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 208
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 206
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 205
Naloxone-reverisble antinociception by paracetamol in the rat. 199
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 192
Chronic treatment with phenazone modifies pontine noradrenergic receptors in rats. 189
Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis 188
EFFECTS OF ACETYLSALICYCLIC ACID ON SEROTONIN BRAIN RECEPTOR SUBTYPES 187
Effect of hypericum perforatum extract in an experimental model of binge eating in female rats 182
Naltrexone and 6-Beta-naltrexol concentration/time profile in the treatment of opiate dependence 169
Lack of activity of azapropazone in the hot-plate test and in 5-HT1A and 5-HT2 receptor subtypes in rat brain membranes 163
Serum levels of naltrexone and 6-beta-naltrexol after oral naltrexone in patients with liver cirrhosis 156
Plasma time-course of naltrexone and 6beta-naltrexol levels after oral administration in drug addicts and in patients with liver cirrhosis 146
Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study 142
Chemical Characterization and Beneficial Effects of Walnut Oil on a Drosophila melanogaster Model of Parkinson’s Disease 134
Characterization of Walnut Oil and Evaluation of Its Neuroprotective Effects in an In Vitro Model of Parkinson’s Disease 95
Totale 17.156
Categoria #
all - tutte 64.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021385 0 0 0 0 0 0 0 0 0 209 89 87
2021/20221.318 40 156 157 76 37 37 101 64 148 99 257 146
2022/20231.341 163 152 86 124 147 207 22 118 137 30 55 100
2023/2024650 36 36 49 54 162 43 34 93 11 17 52 63
2024/20252.692 86 16 44 176 566 388 225 136 298 160 293 304
2025/20265.489 405 273 437 779 1.126 448 648 297 598 478 0 0
Totale 17.156